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Abstract  Microcalciﬁcations  are  actually  indirect  signs  of  pathological  processes,  and  only  a
few of  these  processes  may  be  correctly  correlated  to  the  morphologic  pattern  of  calciﬁca-
tions. This  is  true  of  the  microcalciﬁcations  typically  classiﬁed  as  benign  by  the  4th  edition  of
the BI-RADS  Atlas,  except  for  round  and  punctuate  microcalciﬁcations.  This  is  also  the  case  of
polymorphous  ﬁne  and  linear  ﬁne  microcalciﬁcations  most  often,  but  not  exclusively,  associated
with DCIS  with  necrosis.  For  other  types  of  microcalciﬁcations,  other  parameters  are  analyzed
in a  more  global  approach:  the  associated  clinical  or  mammographical  signs;  the  context,  espe-
cially genetic;  the  spatial  distribution;  the  number;  the  evolution  over  time.  The  radiologist
should compare  the  images  with  the  anatomy  of  the  terminal  ductal-lobular  unit,  from  where
most cancers  arise,  and  estimates  the  risk  by  taking  into  account  the  clinical  context  and  the
antecedents.
© 2014  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Breast  microcalciﬁcations  are  present  in  about  30%  of  all  malignant  breast  lesions,  in  over
half  of  the  malignant  infraclinical  breast  lesions,  and  lead  to  depict  85  to  95%  of  all  cases
of  ductal  carcinoma  in  situ  in  screening  campaigns.
Deﬁnition and technical requirements
The  term  microcalciﬁcation  refers  to  calciﬁcations  of  whom  diameter  is  inferior  to  1  mm,
knowing  that  current  spatial  resolution  mammographs  make  small  objects  to  be  detected
without  magniﬁcation  for  a  size  ranged  between  100  and  200  m.
Detection  is,  in  principle,  based  on  the  images  obtained  with  a  magniﬁcation  of  1,  on
installations  complying  with  the  prevailing  quality  control  standards.
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deﬁne  a  lobule  (Fig.  1).42  
Characterization  requires  images  with  a  magniﬁcation  of
t  least  1.5,  using  the  smallest  focal  spot  of  0.1  mm,  accord-
ng  to  the  French  legislation.  The  speciﬁcations  for  the
rench  breast  cancer  screening  program  indicates  that  the
nstallation  should  be  able  to  provide  images  with  geomet-
ic  magniﬁcation,  except  for  installations  providing  a  spatial
esolution  of  50  m,  for  which  magniﬁcation  by  electronic
ethods  are  authorised  [1].
hysiopathology
he  most  common  breast  calciﬁcations  are  dystrophic  and
ccur  in  different,  sometimes  associated,  pathological  pro-
esses:  inﬂammation,  infection,  benign  tumour,  malignant
umour.
They  may  occur  in  the  stroma  of  a  ﬁbrous  lesion  with
 connective  component  (ﬁbroadenoma),  or  in  the  stroma
eaction  of  a  malignant  tumour.
In  the  ductal-lobular  structures,  they  appear  with  two
istinct  mechanisms:
an  accumulation  of  secretions  of  mucin  in  the  lumen  of
the  duct  or  lobular  acini  or  in  the  cavities  formed  by  the
lesion,  such  as  low  or  intermediate  grade  DCIS,  that  cal-
cify  secondarily  taking  a  round  or  amorphous  shape  of
different  size,  of  more  or  less  large  size  depending  on
whether  or  not  the  lumen  is  dilated  [2].  These  microcal-
ciﬁcations  are  not  speciﬁc  to  neoplastic  lesions  and  may
be  found  in  all  pathological  processes  involving  the  ter-
minal  ductal-lobular  unit,  including  simple  or  sclerosing
adenosis,  simple  or  atypical  ductal  or  lobular  epithelial
hyperplasia;
a  calciﬁcation  process  of  endoluminal  necrotic  mate-
rial  consisting  of  cell  debris  and  secretions  produced  by
various  pathological  entities  including  comedocarcinoma,
that  will  ﬁt  closely  around  the  lumen  of  the  ductal-
lobular  structures  providing  linear,  sometimes  granular
microcalciﬁcations,  depending  on  the  amount  of  material
accumulated  in  the  lumen  [2].
igure 1. Anatomy of the terminal ductal-lobular unit: a: systematisat
obular or segmental duct; 4: sub-segmental duct and terminal ducts; 5:
erminal duct; 2: intralobular terminal duct; 3: acinary duct; 4: acinus; 
a
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These  often  easily  recognised  microcalciﬁcations  are  fre-
uently  associated  with  high-grade  ductal  carcinoma  in  situ
ut  are  also,  although  more  rarely,  found  in  extensive  low
nd  intermediate  lesions  or  even  in  benign  lesions  such  as
pithelial  metaplasia  [3].
Most  breast  calciﬁcations  are  made  of  calcium  phos-
hate,  a  small  are  made  of  calcium  oxalate  in  case  of  ductal
ithiasis  (weddelites).
Another  type  results  from  metaplasia  by  cells  that
etabolize  calcium  in  the  collagen  in  response  to  a  post-
raumatic,  post-therapeutic  cytosteatonecrosis  or  following
 haematoma  like  that  occur  in  the  bone  tissue.
orphological analysis and assessment of
he  risk: general principles
orrelation between the radiological images
nd the anatomy of the terminal
uctal-lobular unit
y  analyzing  microcalciﬁcations,  the  radiologist  systemat-
cally  looks  for  signs  compatible  with  a  carcinoma  in  situ.
n  the  ductal  and  lobular  forms,  it  arises  in  the  terminal
uctal-lobular  unit  (TDLU).  It  is  therefore  necessary  to  be
ully  familiar  with  the  histological  characteristics  of  TDLU
n  order  to  be  able  to  establish  a  link  between  the  morphol-
gy  of  the  microcalciﬁcations,  their  distribution,  and  their
uctal-lobular  origin.
The  breast  has  average  15  to  20  lobes  or  segments  that
ive  rise  to  a main  duct  ending  in  a  lactiferous  sinus  in  the
ipple.
Each  duct  divides  from  the  nipple  to  the  periphery  in
ub-segment  ducts  and  then  into  20  to  40  terminal  ducts.
Each  terminal  duct  collects  10  to  100  glandular  acini  thation of the lactiferous network. 1: main duct; 2: lactiferous sinus; 3:
 mammary lobule; b: terminal ductal-lobular unit. 1: extralobular
5: intralobular stroma.
The  entire  length  of  the  walls  of  the  ducts,  to  the  canciuli
nd  the  acini,  are  formed  by  a  continuous  surface  epithe-
ium  in  periphery  surrounded  by  a  discontinuous  layer  of
ogy  
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myo-epithelial  cells.  This  layer  is  coated  with  a  layer  of
slack  connective  tissue  poor  in  collagen  and  rich  in  cells
called  basal  membrane,  the  crossing  of  which  determines
the  micro-invasive  and  then  invasive  nature  of  a  tumor  [3].
The  microcalciﬁcations  associated  with  the  development
of  a  carcinoma  in  situ  arise  in  the  lumen  of  the  acini  and  ter-
minal  ducts,  by  calcium  production  on  the  secretion  material
or  on  the  zones  of  necrosis.  They  only  indirectly  attest
to  the  cell  proliferation  of  the  carcinoma,  that  will  then
progress  in  a  retrograde  direction,  within  the  lobule  or  an
anterograde  direction  in  the  ducts  toward  the  nipple.  The
microcalciﬁcations  may  seem  to  be  discontinuous  and  indi-
cate  multi-focality.  Multifocal  DCIS  lesions  are  actually  rare
and  most  often  may  correspond  to  a  single  lesion  extending
to  several  ducts  by  contiguity  [4].
Size of the microcalciﬁcations
Roughly,  large  microcalciﬁcations  of  about  one  millime-
tre  are  more  often  benign  than  those  whose  size  is  under
0.5  mm.
However,  there  are  exceptions  since  coarse  heteroge-
neous  or  dystrophic  calciﬁcations  over  one  millimetre  in  size
may  associate  with  malignant  lesions.
Number of microcalciﬁcations
A  group  of  10  or  more  microcalciﬁcations  in  a  volume  infe-
rior  to  1  cm3 is  more  suspect  than  a  group  of  5  of  identical
morphology.
In  Barreau’s  study,  the  high  number  of  microcalciﬁcations
in  a  cluster  was  correlated  with  the  high  grade  of  DCIS  and
the  presence  of  necrosis  [5].
Site of origin
The  site  of  the  formation  or  accumulation  of  calciﬁcations
may  determine  their  morphology:
• round  or  punctuate,  of  normal  size  or  dilated,  in  the  lob-
ular  acini,  most  often  associated  with  benign  lesions  or
low  grade  carcinoma  in  situ;
• linear  in  the  lumen  of  a  small  duct  by  calciﬁcation  of
a  zone  of  necrosis  associated  with  a  high  grade  ductal
carcinoma  in  situ  or  by  rod-like  calciﬁcations  of  secreti-
ons  accumulated  in  a  larger  duct  as  a  consequence  of  a
galactophoritis;
• coarse  in  the  connective  tissue  of  an  adenoﬁbroma  or  in
the  stroma  reaction  of  invasive  carcinoma.
Distribution according to the aetiology
The  pathological  process  that  produces  the  microcalciﬁca-
tions  may  determine  their  distribution:
• round  clustered  distribution  or  regional  distribution  in  thelumen  of  multiple  lobular  acini  in  case  of  adenosis,  lesions
involving  a  risk  or  certain  DCIS;
• segmental  arrangement  in  the  caniculi  and  ducts  of  a  lobe
in  case  of  extensive  DCIS;
• diffuse  distribution  in  case  of  ﬁbrocystic  dystrophy  in  cysts
or  dilated  acini.
o
I
a
b
b143
volution over time: is stability a guarantee of
enignness?
tability  over  time  is  classically  considered  to  be  less  sus-
ect,  suggesting  benign  histology.  This  concept  applies  when
 mammography  image  is  classiﬁed  ACR  3.  A  control  after  4  o
 months,  then  6  months  later,  then  1  year  later  is  the  usual
ollow-up  schedule  for  an  anomaly  thought  to  be  probably
enign  with  a  risk  of  malignancy  that  does  not  exceed  2%
uring  the  assessment  of  practices.
In  the  analysis  of  microcalciﬁcations,  decision  of  follow-
p  should  only  apply  to  certain  microcalciﬁcations  featuring
on-suspect  semiological  criteria:
a  few,  round  or  punctuate  clustered  microcalciﬁcations;
a few,  amorphous  microcalciﬁcations  in  a  small  round
or  oval  cluster,  onset  calciﬁcation  process  of  a  ﬁbroade-
noma;
coarse,  heterogeneous  microcalciﬁcations,  grouped  on  a
small  volume,  suggesting  a  calciﬁed  ﬁbroadenoma.
For  other  microcalciﬁcations  not  combining  these  crite-
ia,  the  stability  over  time  should  not  be  considered  to  be
robably  benign.
Lev-Toaff,  in  a  series  of  105  cases  of  malignant  micro-
alciﬁcations,  analysed  the  evolution  of  the  anomalies  by
omparison  with  the  previous  mammograph  performed  8  to
3  months  before  (mean:  25.4  months).  The  microcalciﬁca-
ions  were  unchanged  in  24.8%  of  the  cases  [6].
ssociated mammography signs
pacity  associated  with  the  microcalciﬁcations  increases
he  probability  of  malignancy,  mostly  invasive  carcinoma.
linical context and antecedents
icrocalciﬁcations  that  may  be  considered  as  probably
enign  in  the  general  population  are  more  suspect  in  case  of
n  anomaly  in  the  clinical  examination,  a  personal  history
f  breast  cancer  or  a  genetic  predisposition.
Clustered  classiﬁcation  that  would  have  been  classiﬁed
s  ACR  3  in  the  general  population  often  leads  to  biopsy  in
 woman  with  a  genetic  risk.
Microcalciﬁcations  appearing  not  typical  of
ytosteatonecrosis  in  a  treated  breast  should  undergo
istological  veriﬁcation.
he different types of microcalciﬁcations:
hat are the risks?
y  deﬁnition,  calciﬁcations  over  one  millimetre,  such  as
op-corn-like  calciﬁcations  and  large  rod-like  calciﬁcations
re  excluded.
he BI-RADS system of the American College
f Radiologyt  was  developed  in  order  to  standardise  the  description
nd  recommendations  for  the  care  of  anomalies  detected
y  mammography,  and  as  a  result,  facilitate  communication
etween  radiologists  and  referring  physicians.
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It  is  useful  to  evaluate  the  assessment  of  the  radiological
ractices  and  helps  to  standardise  practices.
It  is  also  a  unique  way  to  be  able  to  compare  publica-
ions  by  using  a  common  language  that  was  sadly  missing
n  the  past  (for  example,  the  same  type  of  microcalciﬁca-
ions  could  be  labelled  lobular,  round  or  granular  in  different
ublications  published  before  the  BI-RADS  system,  or  even
n  recent  publications  that  do  not  use  it).
The  section  dealing  with  microcalciﬁcations  is  inspired
y  previous  classiﬁcations,  such  as  Le  Gall’s  classiﬁcation.
It  deﬁnes  the  descriptive  elements  concerning  the  mor-
hology  of  the  different  types  of  breast  calciﬁcations,  and
escribes  three  categories:  typically  benign,  intermediate
isk  of  malignancy,  higher  probability  of  malignancy.  It  adds
escriptive  elements  concerning  the  spatial  distribution  of
he  calciﬁcations:
the scattered  or  diffuse  nature;
the  regional  distribution,  corresponding  to  calciﬁcations
scattered  over  a  large  volume  (>  2  cc  of  breast  tissue)
without  a  ductal  distribution;
clustered  calciﬁcations,  containing  at  least  5  microcalci-
ﬁcations  in  a  small  volume  of  tissue  (<  1  cc);
the  linear  distribution  suggesting  ductal  extension;
the  segmental  distribution,  of  triangular  shape  with  the
tip  directed  towards  the  nipple,  suggesting  a  neoplastic
process  extending  into  a  lobe  or  a  segment  of  the  breast.
In  practice,  these  modiﬁers,  as  a  function  of  the  spa-
ial  distribution,  will  modulate  the  degree  of  suspicion  of
ound/punctuate  and  amorphous  microcalciﬁcations:  less
uspicion  in  case  of  scattered  or  diffuse  distribution,  slightly
ess  in  case  of  regional  distribution,  higher  suspicion  in  case
f  grouping  in  a  focal  point  or  cluster,  of  segmental  or  linear
istribution.
The  current  version  is  the  4th  edition  published  in  2003
7].  It  has  modiﬁed  some  elements  of  the  morphological
escription  by  splitting  the  former  ‘‘polymorphous’’  cat-
gory  into  two  categories:  ‘‘coarsely  heterogeneous’’  and
‘ﬁne  polymorphous’’.  In  the  typically  benign  category,  it
ncludes  round  and  punctuate  microcalciﬁcations,  and  this
oint  is  a  subject  of  controversy  in  the  literature.
ypically benign microcalciﬁcations that
on’t require histological veriﬁcation
utaneous or dermal calciﬁcations
hey  do  not  generate  diagnostic  problems  in  mammogra-
hy,  appearing  round,  lucent-centred  and  ring-shaped  and
ith  a  light  centre.  They  predominate  in  the  sub-mammary,
xillary,  areolar  and  parasternal  regions,  more  rich  in  sub-
utaneous  glands.  When  their  cutaneous  origin  has  not  been
learly  demonstrated,  it  may  be  useful  to  obtain  some  com-
lementary  views  tangential  to  the  skin.
ascular calciﬁcationshey  are  more  frequent  with  age  and  predominate  along
he  external  mammary  vessels.  They  may  form  a  marker
f  atherosclerosis  and  coronary  risk.  They  are  easily  recog-
ised  when  they  present  as  a  long  tram-track  patterns
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long  vessels,  in  particular  in  diabetic  patients.  They  raise
ore  interpretation  problems  when  discontinuous  at  the
eginning  of  the  calciﬁcation  process,  due  to  their  linear  dis-
ribution,  and  in  this  case,  they  may  require  to  histological
eriﬁcation.
ucent-centered calciﬁcations of
ytosteatonecrosis
hey  are  round  or  oval  and  range  from  1  mm  to  1  cm,  with
 light  centre  and  thick  wall.  They  correspond  to  calciﬁed
ytosteatonecrosis,  of  post-traumatic  or  post-therapeutic
rigin,  in  particular  after  radiotherapy.
ggshell or parietal calciﬁcations
hey  are  thin,  less  than  1  mm,  in  the  periphery  of  a  cyst  or
 zone  of  cytosteatonecrosis.
ilk of calcium calciﬁcations
hey  correspond  to  the  sedimentation  of  calciﬁed  secretion
nside  cysts.  Sedimentation  is  only  conﬁrmed  by  performing
 lateral-medial  view,  revealing  the  characteristic  crescen-
ic  teacups  shape.
On  the  cranial-caudal  view,  the  central  part  appears
morphous,  due  to  the  accumulation  of  the  calciﬁed  ﬂuid
t  the  bottom  of  the  cyst.
Certain  authors  have  recommended  to  perform  com-
lementary  ‘‘hanging  breast’’  views  in  order  to  prove  the
obile  sedimentary  nature  in  this  position.
Their  benign  appearance  should  preclude  the  veriﬁcation
f  the  absence  of  other  more  suspect  microcalciﬁcations
earby.
alciﬁed surgical sutures
hey  are  obvious  when  the  calcifying  process  is  complete,
ut  may  raise  problems  of  interpretation  in  cases  of  partial
alciﬁcation.
ystrophic calciﬁcations
hey  appear  in  zones  exposed  to  a  trauma  or  radiation.
Their  shape  is  coarse,  over  0.5  mm.  Other  calciﬁcations
uggesting  cytosteatonecrosis  (lucent-centered  calciﬁca-
ions,  eggshell  calciﬁcations)  are  frequently  associated.
adio-histological correlations
icrocalciﬁcations that may be classed as
enign or suspect: round or punctuate
icrocalciﬁcations
hey  are  included  in  the  category  of  typically  benign  cal-
iﬁcations  in  the  4th  edition  of  the  BI-RADS  system  by  the
merican  College  of  Radiology  (Fig.  2).  Nevertheless,  the
uthors  indicate  that  an  isolated  group  (cluster)  of  punc-
uate  calciﬁcations  may  require  close  follow-up,  or  even  a
iopsy,  if  present  on  the  same  side  as  a  breast  cancer  [7].
Breast  microcalciﬁcations:  The  lesions  in  anatomical  pathology  145
Figure 2. Round and punctuate microcalciﬁcations: a: lateral medial view: infracentimetric focus at the union of the outer quadrants of
the right breast (arrow); b: lateral medial and (c) craniocaudal view with magniﬁcation: clustered punctuate microcalciﬁcations (arrow) with
several round calciﬁcations (small arrow) with angular contours comprising more than 10 elements classiﬁed as ACR 4B; d: vacuum assisted
breast macrobiopsies: Presence of representative microcalciﬁcations (arrows); e: histology (low magniﬁcation): simple, non-atypical, focally
hyperplastic, cylindrical metaplasia. Microcalciﬁcations (blue arrows) in the lumen of the acini of a lobule (red arrows); f: histology (high
mangiﬁcation): simple cylindrical, non-atypical, focally hyperplastic metaplasia. Microcalciﬁcations in the lumen of the acini of a lobule
(red arrows). Epithelial lesions of cylindrical non-atypical metaplasia (blue arrow). Presence of several aspects of grade 2 lobular neoplasm
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This  choice  has  given  rise  to  a  controversy  in  the
literature  and  certain  authors  propose  classifying  these
microcalciﬁcations  as  suspect.
They  classically  consist  of  microcalciﬁcations  arising  in
the  lumen  of  lobular  acini,  called  round  when  they  exceed
0.5  mm  and  punctuate  below  0.5  mm.
In  a  great  many  recent  publications,  they  do  not  seem  to
be  individualised  as  such  in  the  ‘‘typically  benign’’  category,
with  a  rate  of  cancer  reported  as  null  in  this  category  [8—10].
However,  in  certain  studies,  certain  punctuate  microcalciﬁ-
cations  may  be  classiﬁed  as  amorphous  microcalciﬁcations,
or  even  ﬁne  polymorphous  microcalciﬁcations,  as  the  stud-
ies  on  the  inter-  and  intra-observer  reproducibility  have
revealed  great  disparities  [11].
Le  Gall’s  work  reported  the  presence  of  malignancy  asso-
ciated  with  regular  punctuate  microcalciﬁcations  in  19%  of
the  cases  [12].De  Lafontan  reported  a  malignancy  of  10%  of  cancer  for
punctuate  microcalciﬁcations  [13].
In  a  meta-analsysis  on  40  publications  and  10,665  cases
of  microcalciﬁcations,  Rominger  reported  a  global  rate  of
a
l
oalignancy  for  round  and  punctuate  microcalciﬁcations  of
%  (6—13%),  of  14%  (11—19%)  in  the  sub-group  that  ben-
ﬁted  from  systematic  histological  veriﬁcation  and  0.5%
0.08—2.57%)  in  a  sub-group  that  beneﬁted  from  2  years  of
ollow-up  [14].
Holland  reported  that  the  round  or  punctuate  microcalci-
cations  are  those  usually  found  in  well-differentiated  DCIS
15]. Evans  reported  that  round  and  punctuate  microcalciﬁ-
ations  are  more  frequently  associated  with  positive  margins
uring  excision  surgery  of  DCIS  than  polymorphous  and  ﬁne
inear  microcalciﬁcations,  and  suggests  that  these  microcal-
iﬁcations  are  more  often  associated  with  DCIS  comprising
on-calciﬁed  extensions  not  seen  in  mammography  [16].
Evans  indicated  that  these  round  microcalciﬁcations  are
ore  frequent  in  cribriform  DCIS  without  necrosis  [17].
Barreau  reported,  in  58  cases  of  DCIS  detected  by  round
icrocalciﬁcations,  65.6%  grade  I  DCIS,  17.2%  grade  2  DCIS
nd  17.2%  grade  3 DCIS  [5].
Evans  found  punctuate  microcalciﬁcations  in  22%  of  the
ow  grade  DCIS,  20%  of  the  intermediate  grade  DCIS  and  9%
f  the  high  grade  DCIS  [18].
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These  microcalciﬁcations  may  be  found  in  all  patholog-
cal  processes  involving  the  terminal  ductal-lobular  unit,
ncluding  simple  or  sclerosing  adenosis,  ductal  or  lobular,
imple  or  atypical,  epithelial  hyperplasia.
In  2002,  the  ANAES  proposed  considering  as  probably
enign  (ACR  3),  a  few  round  or  punctuate  microcal-
iﬁcations  (the  threshold  of  10  microcalciﬁcations  was
ften  reported)  in  small  round  isolated  clusters  and
roposed  a  histological  veriﬁcation  for  more  numerous
ound  or  punctuate  microcalciﬁcations  (ACR  4)  and/or
hose  grouped  in  clusters  with  neither  round  nor  oval
argins  [18].
In  his  meta-analysis,  Rominger  indicated  that  the  dif-
erent  items  of  descriptions  of  the  spatial  distribution
f  round  or  punctuate  microcalciﬁcations  are  associ-
ted  with  an  overall  rate  of  malignancy  that  remains
uperior  to  2%,  and  recommends  classifying  them  as
CR4  whatever  the  mode  of  distribution  or  number.  For
he  different  descriptions,  he  reports:  in  small  clus-
ers,  7.66%  of  malignancy  (2.49—21.23%);  diffuse,  5.67%
0.36—50.05%);  regional  22.63%  (3.27—71.65%);  segmen-
al  21.41%  (8.73—43.72%);  linear  21.74%  (4.33—63.03%)
14].
o
4
igure 3. Amorphous microcalciﬁcations: a: lateral medial view: Mic
f the right breast, poorly visible (arrows); b: lateral medial and (c) cra
icrocalciﬁcations, with regional distribution (arrows) classiﬁed as ACR 4
rrow); d: vacuum assisted breast macrobiopsies: poorly visible represent
brous fatty breast tissue comprising several aspects of sclerosing aden
istology (high magniﬁcation): ﬁbrous fatty breast tissue comprising se
umen of the lobular acini where the epithelium is no longer visible (redP.  Henrot  et  al.
uspect microcalciﬁcations or intermediate
evel of concern
morphous  or  indistinct  microcalciﬁcations
lso  called  tiny  or  hazy  microcalciﬁcations,  about  200  to
00  m,  they  are  less  conspicuous  than  the  other  microcal-
iﬁcations  and  require  technically  optimised  mammograms
Fig.  3).
They  are  found  in  the  benign  pathological  processes
ﬁbrocystic  dystrophy),  lesions  at  risk  or  non-comedo  car-
inoma  in  situ.
Descriptor  items  of  the  spatial  distribution  play  a  major
ole  in  the  assessment  of  the  risk  associated  with  these
icrocalciﬁcations:  scattered  or  diffuse,  they  are  con-
idered  to  be  probably  benign;  in  clustered,  regional,
egmental  or  linear,  they  are  considered  as  suspect.
In  2002,  the  ANAES  proposed  classifying  as  probably
enign  ACR  3,  a  few  amorphous  microcalciﬁcations  in  small,
ound  or  oval,  amorphous  clusters,  not  abundant  microcal-
iﬁcations,  suggesting  the  beginning  of  calciﬁcation  process
f  a  ﬁbroadenoma,  and  proposed  classifying  as  suspect  ACR
,  abundant  and  grouped  microcalciﬁcations  [19].
rocalciﬁcations extending over 3 cm in the upper outer quadrant
niocaudal view magniﬁcation: association of abundant amorphous
A, and several rare coarse heterogeneous microcalciﬁcations (small
ative microcalciﬁcations (arrows); e: histology (low magniﬁcation):
osis. Microcalciﬁcations distributed in several lobules (arrows); f:
veral aspects of sclerosing adenosis. Microcalciﬁcations ﬁlling the
 arrows). Zone of intralobular ﬁbrosis (blue arrow).
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Barreau  reported,  in  146  cases  of  DCIS  detected  by  amor-
phous  microcalciﬁcations,  71.6%  grade  1  DCIS,  13.2%  grade
2  DCIS  and  15.2%  grade  3  DCIS  [5].
Berg  reported  a  rate  of  malignancy  of  20%  for  amorphous
microcalciﬁcations.  De  Lafontan  reported  a  malignancy  of
19%  [20].
In his  series,  in  the  sub-group  of  amorphous  microcalciﬁ-
cations,  Burnside  reported  7%  invasive  carcinoma,  7%  DCIS,
13%  lesions  at  risk  [8].
Bent  et  al.  reported  a  rate  of  malignancy  of  20%,  10%
invasive  carcinoma  and  10%  DCIS  [9].
Shin  et  al.  reported  7%  invasive  carcinoma,  24%  DCIS,  8%
lesions  at  risk  [10].
In  his  meta-analysis,  Rominger  reported  a  rate  of  malig-
nancy  of  27%  for  amorphous  microcalciﬁcations  and  a  global
rate  always  exceeding  2%,  whatever  the  descriptor  items  of
spatial  distribution,  including  scattered  microcalciﬁcations
where  the  rate  was  6.98%  (0.94—37.16%)  [14].Coarse  heterogeneous  microcalciﬁcations
Recently  individualised,  they  refer  to  microcalciﬁcations
exceeding  0.5  mm  those  are  easily  visible,  irregular,
o
t
s
(
Figure 4. Coarse heterogeneous microcalciﬁcations: a: CC view withou
ciﬁcations of 5 mm (arrow); b: front and (c) proﬁle view with magniﬁcatio
with a linear distribution, classiﬁed as ACR 4B (arrow); d: vacuum assisted
contrast (arrow); e: histology (low magniﬁcation): nodular lesion of 0.4 c
corresponding to a ﬁbroadenoma with ﬁbrous stroma, with big scattered
microcalciﬁcations (blue arrows) and small microcalciﬁcations (small arro
a margin of ﬁbrous fatty tissue poor in glandular structures, correspon
calciﬁcations. Calciﬁcations developed within the stroma (arrows) witho147
ending  to  coalesce  (Fig.  4).  The  size  remains  inferior  to
hat  of  dystrophic  calciﬁcations  and  superior  to  that  of  ﬁne
olymorphous  calciﬁcations.
They  correspond  to  the  usual  appearance  of  ﬁbroadeno-
atous  lesions  or  ﬁbrotic  lesions,  but  may  also  be  found
n  malignant  lesions.  Modiﬁcators  of  the  spatial  distribution
hould  be  taken  into  account  in  estimating  the  risk  of  malig-
ancy:  probable  calciﬁed  ﬁbroadenoma  in  case  of  compact
lustered  microcalciﬁcations  grouped  over  a  small  volume,
uspect  lesion  in  the  case  of  segmental  distribution.
Burnside  reported,  in  his  series,  in  the  sub-group  of  14
ases  of  coarse  heterogeneous  microcalciﬁcations,  only  one
ase  of  DCIS,  no  cases  of  invasive  carcinoma,  or  lesions  at
isk  [8].
In  10  cases,  Bent  et  al.  reported  2  cases  of  DCIS  and  no
ases  of  invasive  carcinoma  [9].
In  110  cases,  Shin  et  al.  reported  6%  invasive  carcinoma,
5%  DCIS,  12%  lesions  involving  a  risk  [10].
In  his  meta-analysis,  Rominger  reported  13%  (7—20%)
f  malignancy  for  coarse  heterogeneous  microcalciﬁca-
ions,  12.02%  (5.22—25.29%)  when  they  are  in  small  focal
pots,  25%  (8.34—89.11%)  when  they  are  regional,  16.67%
0.95—80.64%)  when  they  are  linear  [14].
t magniﬁcation: focus of outer retromammary clustered microcal-
n: presence of about ten coarse heterogeneous microcalciﬁcations
 breast macrobiopsies: representative microcalciﬁcations with low
m with a margin of ﬁbrous fatty tissue poor in glandular structures,
 calciﬁcations. Nodule with distinct margins (tips of arrows). Large
w); f: histology (high magniﬁcation): nodular lesion of 0.4 cm with
ding to a ﬁbroadenoma with ﬁbrous stroma, with big scatterered
ut epithelial structure.
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icrocalciﬁcations with a higher probability of
alignancy
hey  are  easily  visible  and  usually  feature  a  spatial  distribu-
ion  suggesting  ductal  neoplasm.  They  are  often  associated
ith  calciﬁed  necrosis  moulded  in  the  ducts  in  case  of  high-
rade  comedo  carcinoma  or  intermediate  grade  DCIS  with
ecrosis.
ine  polymorphous  microcalciﬁcations
ecently  individualised,  they  correspond  to  calciﬁcations
hose  size  is  under  0.5  mm,  and  are  more  visible  than  amor-
hous  microcalciﬁcations  (Fig.  5).
They  suggest  malignancy  as  ﬁrst  choice  and  require  his-
ological  veriﬁcation.
Barreau  reported,  for  103  cases  of  DCIS  detected  by  ﬁne
olymorphous  microcalciﬁcations,  44.6%  grade  1  DCIS,  16.9%
rade  2  DCIS  and  38.5%  grade  3  DCIS  [5].
In  a  series  of  77  cases  of  ﬁne  polymorphous  microcalci-
cations,  Hofvind  reported  the  presence  of  high  grade  DCIS
n  69%  [21].
Burnside  reported  in  his  series,  in  the  sub-group  of  ﬁne
olymorphous  microcalciﬁcations,  15%  invasive  carcinoma,
5%  DCIS,  3%  lesions  at  risk  [8].
t
e
D
c
igure 5. Fine polymorphous microcalciﬁcations: a: strict proﬁle vie
arrow); b: proﬁle and (c) front view with magniﬁcation: ﬁne polymorp
C (arrows); d: vacuum assisted breast macrobiopsies: representative m
rade nuclear ductal carcinoma in situ with necrosis and microcalciﬁcati
n the lumen of a duct (red arrow). Necrosis with ﬁne calciﬁcations (yel
istology (high magniﬁcation): High grade nuclear ductal carcinoma in s
ype. Calciﬁcations developed on areas of necrosis in the lumen of the du
red arrow).P.  Henrot  et  al.
Bent  et  al.  reported  28%  malignancy,  12%  invasive  carci-
oma  and  16%  DCIS  [9].
In  58  cases,  Shin  et  al.  reported  26%  invasive  carcinoma,
0%  DCIS,  3%  lesions  at  risk  [10].
In  his  meta-analysis,  Rominger  reported  a  rate  of  malig-
ancy  of  50%  (43—58%)  [14].
ine  linear  or  ﬁne  linear  branched  calciﬁcations
hey  are  linear  or  irregular  curvilinear,  sometimes  discon-
inuous,  under  0.5  mm  (Fig.  6).  They  are  easily  visible  and
sually  identiﬁed  as  suspect,  classiﬁed  ACR  4,  or  even  ACR
 when  the  distribution  is  segmental.
Barreau  reported,  in  21  cases  of  DCIS  detected  by  ﬁne
inear  branched  microcalciﬁcations,  30%  grade  1  DCIS,  11.4%
rade  2  DCIS  and  58.6%  grade  3  DCIS  [5].
Evans  found  ﬁne  linear  microcalciﬁcations  in  58%  of  the
igh  grade  DCIS,  38%  of  the  intermediate  grade  DCIS  and  26%
f  the  low  grade  DCIS  [18].  He  indicated  that  these  micro-
alciﬁcations  are  not  only  found  in  high  grade  DCIS  and  that
he  incidence  of  linear  microcalciﬁcations  increases  with  the
xtent  of  the  microcalciﬁcations,  whatever  the  grade  of  the
CIS.  He  reported  that  the  incidence  of  linear  microcalciﬁ-
ations  in  a small  cluster,  under  10  mm,  of  high  grade  DCIS
w: outer retromammary microcalciﬁcations extending over 3 cm
hous microcalciﬁcations with linear distribution classiﬁed as ACR
icrocalciﬁcations (arrows); e: histology (low magniﬁcation): high
ons, of the comedocarcinoma type. Necrosis without calciﬁcations
low arrow). Calciﬁcations without visible necrosis (blue arrow); f:
itu with necrosis and microcalciﬁcations, of the comedocarcinoma
cts (blue arrows). Calciﬁcations without visible associated necrosis
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Figure 6. Fine linear and ﬁne branched microcalciﬁcations: a: LM view: extensive weakly contrasted microcalciﬁcations in a large right
upper outer quadrant (arrows); b: LM and (c) CC view with magniﬁcation: ﬁne linear microcalciﬁcations (arrows) and ﬁne linear branched
microcalciﬁcations (small arrows) with segmental distribution over 9 cm (arrows) classiﬁed as ACR 5; d: Vacuum assisted breast macrobiopsies
macrobiopsies: representative microcalciﬁcations (arrows); e: histology (low magniﬁcation): lesions of high grade nuclear ductal carcinoma
in situ with necrosis and calciﬁcations. Area of necrosis without calciﬁcations in the lumen of a duct (red arrow). Area of necrosis with
e nec
catio
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ccalciﬁcations (blue arrow). Calciﬁcations without associated visibl
high grade nuclear ductal carcinoma in situ with necrosis and calciﬁ
arrow). Calciﬁcations without visible associated necrosis (yellow arr
is  identical  to  that  found  in  an  intermediate  grade  DCIS  of
21  to  30  mm  and  in  a  low  grade  DCIS  of  over  30  mm.
Hofvind  reported,  in  series  of  62  cases  of  ﬁne  linear
microcalciﬁcations,  the  presence  of  high  grade  DCIS  in  84%
[21].
Burnside  reported  in  his  series,  in  the  sub-group  of  ﬁne
linear  calciﬁcations,  32%  invasive  carcinoma,  21%  DCIS,  5%
lesions  at  risk  [8].
Bent  et  al.  reported  70%  malignancy,  22%  invasive  carci-
noma  and  48%  DCIS  [9].
In  35  cases,  Shin  et  al.  reported  23%  invasive  carcinoma,
69%  DCIS,  6%  lesions  involving  a  risk  [10].
In  his  meta-analysis,  Rominger  reported  a  rate  of  malig-
nancy  of  78%  (68—86%)  [14].
Conclusion
Microcalciﬁcations  are  actually  indirect  signs  of  pathological
processes,  some  of  which  may  only  be  correctly  identiﬁed
according  to  their  morphology.  This  is  true  for  the  microcal-
ciﬁcations  classiﬁed  as  typically  benign  in  the  4th  edition  of
the  BI-RADS  system,  except  for  round  and  punctuate  micro-
calciﬁcations.  This  is  also  true  of  ﬁne  polymorphous  and
ﬁne  linear  microcalciﬁcations  that  are  more  often,  but  not
a
(
w
trosis (yellow arrow); f: histology (high magniﬁcation): lesions of
ns. Area of necrosis with calciﬁcations in the lumen of a duct (red
 Cluster of carcinomatous cells in the lumen of a duct (blue arrow).
xclusively,  associated  with  ductal  carcinoma  in  situ  with
ecrosis.
For  other  types  of  microcalciﬁcations,  other  parameters
re  analyzed  in  a  more  global  approach:
the  signs  associated  and,  ﬁrst,  the  ﬁndings  of  the  clinical
examination,  and  the  associated  mammographic  opaci-
ties;
the  context  and  in  particular  the  genetic  risk  of  breast
cancer;
the  type  of  spatial  distribution;
the  number;
the stability  over  time,  which  does  not  eliminate  malig-
nancy  when  the  microcalciﬁcations  are  suspect.
This  multiparameter  approach  is  even  more  complex  due
o  the  poor  inter-observer  as  well  as  intra-observer  repro-
ucibility,  in  classifying  the  different  microcalciﬁcations  by
orphological  type.
Moreover,  it  is  especially  difﬁcult  to  classify  micro-
alciﬁcations  by  morphological  type  when  several  types
re  found  in  the  same  area,  which  is  a frequent  case
Fig.  7).  The  rule  is  to  choose  the  risk  associated
ith  the  most  suspect  microcalciﬁcations.  In  practice,
he  determination  of  the  uniform  or  polymorphous
150  P.  Henrot  et  al.
Figure 7. Different types of microcalciﬁcations: a: front view without magniﬁcation: microcalciﬁcations extending over 5 cm in the
upper outer quadrant of the left breast (arrows); b: exaggerated front with Cleopatra view and (c) proﬁle with magniﬁcation: round
spaced out microcalciﬁcations (large arrows), dystrophic calciﬁcations with milk of calcium (small arrow) and amorphous calciﬁcations
arranged in compact focal points (tip of arrow). The classiﬁcation chosen is ACR 4A on the amorphous microcalciﬁcations; d: sample after
macrobiopsies: representative microcalciﬁcations including the focus of amorphous microcalciﬁcations (tip of arrow); e: histology (low
magniﬁcation): ﬁbrous breast tissue comprising focal points of adenosis with microcalciﬁcations and a great many aspects of cylindrical
metaplasia with papillary ductal hyperplasia. Dilated acini comprising intraluminal high-density microcalciﬁcations (blue arrows) and low-
d ﬁcation): ﬁbrous breast tissue comprising focal points of adenosis with
m  with papillary ductal hyperplasia. High-density microcalciﬁcations (red
a en of dilated lobular acini.
n
g
a
sensity microcalciﬁcations (green arrows); f: histology (high magni
icrocalciﬁcations and a great may aspects of cylindrical metaplasia
rrows) and low-density microcalciﬁcations (blue arrows) in the lumature  of  ﬁne  microcalcﬁcations  is  subject  to  a
reat  subjectivity.  A  multidisciplinary  radio-surgical
nalysis  during  a  formal  exchange  may  be  the  way  to
tandardise  practices  when  confronted  with  difﬁcult  cases.
TAKE-HOME  MESSAGES
• Microcalciﬁcations  are  under  1  mm.  Magniﬁcation  of
1.5  using  the  smallest  focal  spot  of  0.1  mm  are
required  for  their  characterisation.
• They  are  indirect  sign  of  different  pathological
process:  inﬂammation,  infection,  benign  lesions,
malignant  lesions.
• Microcalciﬁcations  associated  with  malignant  lesions
develop  at  the  terminal  ductal-lobular  unit.
• Microcalciﬁcations  classiﬁed  as  typically  benign  in
the  4th edition  of  the  BI-RADS  system  do  not  require
histological  veriﬁcation,  except  for  certain  round  or
punctuate  microcalciﬁcations.
• Round  or  punctuate  microcalciﬁcations  as  well
as  amorphous  or  indistinct  microcalciﬁcations  are
developed  on  secretions  in  the  lobular  acini.They  may  be  associated  with  benign  lesions  or  ductal
carcinoma  in  situ,  usually  without  necrosis.
• Coarse  heterogeneous  microcalciﬁcations  may  be
associated  with  ﬁbroadenomas  or  ﬁbrosis  lesions,  but
may  be  associated  with  malignancy.
• Fine  polymorphous  and  ﬁne  linear  microcalci-
ﬁcations  are  developed  in  the  terminal  ducts  of  the
terminal  ductal-lobular  unit  and  are  often  associated
with  ductal  carcinoma  in  situ  with  necrosis.  They
progress  in  the  ducts  towards  the  nipple.
• Fine  or  polymorphous  and  ﬁne  linear  microcalciﬁ-
cations  are  suspect  and  classiﬁed  ACR  4  or  5.
• Round  or  punctuate  microcalciﬁcations,  amorphous
or  indistinct  microcalciﬁcations  and  coarse  hetero-
geneous  microcalciﬁcations  are  classiﬁed  ACR  2,
3,  4  or  5  according  to  their  spatial  distribution,
number,  evolution  over  time,  associated  clinical
signs,  antecedents  and  the  genetic  predisposition  to
breast  cancer.
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Case report
A  44-year-old  woman  with  antecedents  of  ductal  carcinoma
in  situ  of  the  upper  inner  quadrant  of  the  right  breast,
treated  by  conservative  surgery  followed  by  radiotherapy
(Fig.  8).
Detection  of  two  small  focal  clusters  of  microcalciﬁ-
cations  on  the  right  breast  (arrow  and  arrow  head)  on  a
mammogram  performed  1  year  after  the  end  of  the  treat-
ment  (Fig.  8a—c).
Questions
1.  Indicate  the  morphological  type  and  spatial  distribution
of  the  upper  and  medial  microcalciﬁcations  (arrow  head)
according  to  the  BI-RADS  system  by  the  American  College
of  Radiology.
2.  Indicate  the  morphological  type  and  spatial  distribu-
tion  of  the  upper  and  central  microcalciﬁcations  (arrow)
according  to  the  BI-RADS  system  by  the  American  College
of  Radiology.3.  What  ACR  classiﬁcation  do  you  propose  for  both  anoma-
lies?  What  do  you  recommend?
Figure 8. Fine polymorphous microcalciﬁcations of the upper inner q
magniﬁcation; c: proﬁle view with magniﬁcation; d: macrobiopsies targe
upper inner quadrant. Representative samples (arrows); e: histology (low
and microcalciﬁcations. Calciﬁcations in the lumen of a duct without ne
(black arrow); f: histology (high magniﬁcation): High grade ductal carc
proliferation with atypia of the epithelium of a duct (asterisk). Necrosi
zone of calciﬁed necrosis (black arrow). Endoluminal calciﬁcations witho151
nswers
.  The  microcalciﬁcations  are  ﬁne  polymorphous,  in  small
focal  clusters  of  less  than  1  cm.
.  The  microcalciﬁcations  are  ﬁne  linear  with  a  linear  dis-
tribution.
.  The  clustered  microcalciﬁcations  of  ﬁne  polymorphous
upper  and  medial  quadrant  may  be  classiﬁed  as  ACR  4C.
They  are  often  associated  with  high-grade  ductal  carci-
nomas  in  situ  with  necrosis.  In  a  meta-analysis  on  10,665
cases  of  breast  microcalciﬁcations,  Rominger  reported
a  rate  of  malignancy  of  50%  (43—58%)  for  ﬁne  poly-
morphous  microcalciﬁcations.  In  this  case,  they  may  be
classiﬁed  as  ACR  5 considering  their  appearance  in  a
breast  previously  treated  for  ductal  carcinoma  in  situ,
thereby  increasing  the  risk  of  cancer.  The  aligned  ﬁne
linear  microcalciﬁcations  may  be  classiﬁed  as  ACR  5.
They  are  most  often  associated  with  high-grade  ductal
carcinomas  with  necrosis.  Rominger  reported  a  rate  of
malignancy  of  78%  (68—86%)  for  this  type  of  microcalciﬁ-
cations.  Their  appearance  in  a  breast  previously  treated
for  ductal  carcinoma  in  situ  increases  the  risk  of  cancer
[22].
uadrant: a: front view without magniﬁcation; b: front view with
ting the focal point of ﬁne polymorphous microcalciﬁcations in the
 magniﬁcation): high grade ductal carcinoma in situ with necrosis
crosis (white arrow). Non-calciﬁed necrosis in the lumen of a duct
inoma in situ with necrosis and microcalciﬁcations. Anarchic cell
s during calciﬁcation in the lumen of a duct (white arrow) near a
ut associated necrosis (tip of arrow).
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Surgery  is  indicated.  First,  macrobiopsies  are  indicated
Fig.  8d—f)  in  order  to  conﬁrm  the  diagnosis  of  a  local  recur-
ence,  and  increase  a  proposal  for  non-conservative  surgery,
 ﬁrst  line  option  for  a  recurrence  in  an  irradiated  breast.
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